SISB INVESTMENT ADVISERS (UK) LTD

Institutional investor · Portfolio as of Q4 2020

SEC EDGAR SourceSEC Filings

Top Holdings8 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

UBER TECHNOLOGIES INC

222.2M$11.3B45.6%$46.38+14.60%
7 qtrssince 2019-Q2
Unchanged
0

DOORDASH INC - A

63M$9B36.2%$140.200.00%
1 qtr
New
100

OPENDOOR TECHNOLOGIES INC

73.6M$1.7B6.7%$24.270.00%
1 qtr
New
100

RELAY THERAPEUTICS INC

27.9M$1.2B4.7%$39.98+9.93%
2 qtrssince 2020-Q3
Unchanged
0

Guardant Health, Inc.

6.3M$816.8M3.3%$40.56+211.01%
9 qtrssince 2018-Q4
Decreased
0

VIR BIOTECHNOLOGY INC

22.6M$605.7M2.4%$12.12+132.43%
5 qtrssince 2019-Q4
Unchanged
0

SEER INC

2.9M$162.6M0.7%$56.510.00%
1 qtr
New
62
OCFTOCFTDelisted
ADR

ONECONNECT FINL TECHNOLOGY C

4.4M$87.6M0.4%
$24.8B
AUM
8
Positions
Q4 2020
Filing
Rating · 2.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q4'20
New94%Increased0%Decreased6%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.5 quarters
<1Q38%1-4Q13%1-2Y25%2Y+25%

SB INVESTMENT ADVISERS (UK) LTD manages $24.8B across 8 positions as of Q4 2020. Top holdings: UBER (45.6%), DASH (36.2%), OPEN (6.7%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 2/5.0.

Q4 2020 Summary

Added 4 new positions, trimmed 1. Top move: DASH (NEW, conviction 100). Portfolio: $24.8B across 8 positions.

Top holdings by portfolio weight

Total AUM$25B
UBER45.65%
DASH36.21%
OPEN6.74%
RLAY4.67%
GH3.29%
VIR2.44%
SEER0.65%
OCFT0.35%

Portfolio allocation by GICS sector

Sectors5
Technology45.65%
Consumer Cyclical36.21%
Healthcare11.06%
Real Estate6.74%
Unknown0.35%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Technology, Consumer Cyclical, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track RecordNo data
Conviction37
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used